Cargando…
Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Patients with Cirrhosis and Healthy Volunteers Show Comparable Characteristics
BACKGROUND AND OBJECTIVES: Autologous or allogeneic bone marrow-derived mesenchymal stem cells (BMSCs) have been applied in clinical trials to treat liver disease. However, only a few studies are comparing the characteristics of autologous MSCs from patients and allogeneic MSCs from normal subjects....
Autores principales: | Lim, Yoo Li, Eom, Young Woo, Park, Su Jung, Hong, Taeui, Kang, Seong Hee, Baik, Soon Koo, Park, Kyu-Sang, Kim, Moon Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Stem Cell Research
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691862/ https://www.ncbi.nlm.nih.gov/pubmed/32840228 http://dx.doi.org/10.15283/ijsc20072 |
Ejemplares similares
-
Ca(2+)-activated mitochondrial biogenesis and functions improve stem cell fate in Rg3-treated human mesenchymal stem cells
por: Hong, Taeui, et al.
Publicado: (2020) -
Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
por: Kang, Seong Hee, et al.
Publicado: (2020) -
Mesenchymal stem cells to treat liver diseases
por: Eom, Young Woo, et al.
Publicado: (2020) -
Measuring Intrahepatic Vascular Changes Using Contrast-Enhanced Ultrasonography to Predict the Prognosis of Alcoholic Hepatitis Combined with Cirrhosis: A Prospective Pilot Study
por: Park, Min Sun, et al.
Publicado: (2018) -
The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis
por: Kang, Seong Hee, et al.
Publicado: (2018)